Neuroprotective Effects of Lixisenatide and Liraglutide in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinsons Disease
Intervention Patients in the LC group received 4 g/d L-carnitine infusion (2 g, twice a day) (Lanling Pharmaceutical CO., LTD, Changzhou, China) from the beginning of the pre-fasting day at 9 am and 4 pm to the last day of fasting
Medications maintain therapeutic drug levels continuously, whereas food-stimulated GLP-1 secretion occurs in pulses after meals and is rapidly degraded
Not for human or veterinary application
Patients should be educated on recognizing symptoms of hypoglycemia and keeping fast-acting carbohydrates readily available
Diskare: Ansvara fr att hlla disken i restaurangen ren och i ordning